These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12857381)

  • 1. Use of SAM2 biotin capture membrane in microarrayed compound screening (muARCS) format for nucleic acid polymerization assays.
    Xuei X; David CA; Middleton TR; Lim B; Pithawalla R; Chen CM; Tripathi RL; Burns DJ; Warrior U
    J Biomol Screen; 2003 Jun; 8(3):273-82. PubMed ID: 12857381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarrayed compound screening (microARCS) to identify activators and inhibitors of AMP-activated protein kinase.
    Anderson SN; Cool BL; Kifle L; Chiou W; Egan DA; Barrett LW; Richardson PL; Frevert EU; Warrior U; Kofron JL; Burns DJ
    J Biomol Screen; 2004 Mar; 9(2):112-21. PubMed ID: 15006134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential impact of the HIV-1 non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme function.
    Xu HT; Oliveira M; Quan Y; Bar-Magen T; Wainberg MA
    J Antimicrob Chemother; 2010 Nov; 65(11):2291-9. PubMed ID: 20852269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of specific HIV-1 reverse transcriptase contacts to the viral RNA:tRNA complex by mass spectrometry and a primary amine selective reagent.
    Kvaratskhelia M; Miller JT; Budihas SR; Pannell LK; Le Grice SF
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15988-93. PubMed ID: 12461175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of microarrayed compound screening (microARCS) to identify inhibitors of p56lck tyrosine kinase.
    Freiberg G; Wilkins J; David C; Kofron J; Jia Y; Hirst GC; Burns DJ; Warrior U
    J Biomol Screen; 2004 Feb; 9(1):12-21. PubMed ID: 15006144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare one and two amino acid inserts adjacent to codon 103 of the HIV-1 reverse transcriptase (RT) affect susceptibility to non-nucleoside RT inhibitors.
    Winters MA; Kagan RM; Kovari L; Heseltine PN; Merigan TC
    Antivir Ther; 2005; 10(2):363-6. PubMed ID: 15865232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
    Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
    J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz.
    Kollmann C; Tremblay C; Giguel F; Chou TC; Hirsch MS
    Antivir Ther; 2001 Jun; 6(2):143-4. PubMed ID: 11491419
    [No Abstract]   [Full Text] [Related]  

  • 9. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy.
    Bacheler L; Jeffrey S; Hanna G; D'Aquila R; Wallace L; Logue K; Cordova B; Hertogs K; Larder B; Buckery R; Baker D; Gallagher K; Scarnati H; Tritch R; Rizzo C
    J Virol; 2001 Jun; 75(11):4999-5008. PubMed ID: 11333879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
    Gao HQ; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 reverse transcriptase interaction with model RNA-DNA duplexes.
    Gorshkova II; Rausch JW; Le Grice SF; Crouch RJ
    Anal Biochem; 2001 Apr; 291(2):198-206. PubMed ID: 11401293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized avidin nucleic acid nanoassemblies by a tailored PEGylation strategy and their application as molecular amplifiers in detection.
    Pignatto M; Realdon N; Morpurgo M
    Bioconjug Chem; 2010 Jul; 21(7):1254-63. PubMed ID: 20527874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer.
    Filipowsky ME; Kopka ML; Brazil-Zison M; Lown JW; Dickerson RE
    Biochemistry; 1996 Dec; 35(48):15397-410. PubMed ID: 8952492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitor.
    Romines KR; Freeman GA; Schaller LT; Cowan JR; Gonzales SS; Tidwell JH; Andrews CW; Stammers DK; Hazen RJ; Ferris RG; Short SA; Chan JH; Boone LR
    J Med Chem; 2006 Jan; 49(2):727-39. PubMed ID: 16420058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.
    Delaugerre C; Rohban R; Simon A; Mouroux M; Tricot C; Agher R; Huraux JM; Katlama C; Calvez V
    J Med Virol; 2001 Nov; 65(3):445-8. PubMed ID: 11596076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro.
    Ji X; Klarmann GJ; Preston BD
    Biochemistry; 1996 Jan; 35(1):132-43. PubMed ID: 8555166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel high-throughput format assay for HIV-1 integrase strand transfer reaction using magnetic beads.
    He HQ; Ma XH; Liu B; Chen WZ; Wang CX; Cheng SH
    Acta Pharmacol Sin; 2008 Mar; 29(3):397-404. PubMed ID: 18298906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.
    Gao HQ; Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 2000 Jul; 300(2):403-18. PubMed ID: 10873473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription.
    Lee R; Kaushik N; Modak MJ; Vinayak R; Pandey VN
    Biochemistry; 1998 Jan; 37(3):900-10. PubMed ID: 9454580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis of resilience to the effect of the Lys103Asn mutation in non-nucleoside HIV-1 reverse transcriptase inhibitors studied by targeted molecular dynamics simulations.
    Rodríguez-Barrios F; Balzarini J; Gago F
    J Am Chem Soc; 2005 May; 127(20):7570-8. PubMed ID: 15898808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.